Thymosin Alpha-1 vs Thymosin Beta-4: Which One Wins in 2026?

Thymosin Alpha-1 at a glance:

• Drug class: Immunomodulatory peptide
• Route: subcutaneous injection
• Typical frequency: twice weekly in approved hepatitis B regimens
• Half-life: approximately 2 hours
• Cash price (US): varies by country; not commercially available in US

Both options compared on this page are legitimate choices. The differences below are real but mostly modest. The bigger swing factors are usually outside the molecule itself.

Mechanism

Thymosin Alpha-1: Thymosin alpha-1 is a 28-amino-acid peptide that modulates innate and adaptive immunity, particularly enhancing T-cell function and dendritic cell maturation.

Thymosin Beta-4: Thymosin beta-4 is a naturally occurring 43-amino-acid peptide that binds and sequesters G-actin, regulating cell motility, angiogenesis, and tissue repair.

For people new to this comparison, the practical takeaway is that the underlying mechanisms are different enough that response can vary.

Dosing & Administration

Effectiveness

Thymosin Alpha-1: Improved viral clearance in chronic hepatitis B; investigated in sepsis and cancer immunotherapy.

Thymosin Beta-4: Wound healing, corneal repair, cardiac protection in preclinical and early clinical studies.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully. Reference trials: Multiple hepatitis B trials forming the basis for ex-US approval for Thymosin Alpha-1; RGN-259 phase 3 trials for dry-eye disease and neurotrophic keratopathy for Thymosin Beta-4.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• mild local reactions
• mild ocular irritation in eye-drop trials

Important risks worth knowing for both:

• limited long-term oncology data
• long-term safety not characterized

Cost

Thymosin Alpha-1: varies by country; not commercially available in US. Thymosin Beta-4: pricing varies.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Thymosin Alpha-1 cost and Thymosin Beta-4 cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Thymosin Alpha-1 and Thymosin Beta-4, either is a defensible choice in most cases.

Switching Between Them

Switching from Thymosin Alpha-1 to Thymosin Beta-4 (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

If you and your clinician are split between Thymosin Alpha-1 and a comparator, you're probably in a "no wrong answer" zone. Pick the one with better access for you and reassess in 3 months.

Frequently Asked Questions

Related Reading

• Thymosin Alpha-1 Explained: How It Works and Who It's For
• Thymosin Alpha-1 Side Effects: The Complete List and How to Handle Them
• Does Thymosin Alpha-1 Really Work? An Evidence-Based Results Review
• The Real Thymosin Alpha-1 Price Tag in 2026 — With and Without Insurance
• What Is BPC-157? Everything You Should Know Before Starting
• Is BPC-157 Safe? An Honest Look at the Side-Effect Profile

Sources

• Sikiric P et al. Stable Gastric Pentadecapeptide BPC 157 — Major Wound-Healing Properties. Pharmaceuticals 2020;13:155.
• Goldstein AL et al. Thymosin β4: A Multi-Functional Regenerative Peptide. Annals NY Acad Sci 2012;1269:1.
• Sosne G et al. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy. Expert Opinion 2015;15:663.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.